Nutraceutical Supplements for Inflammatory Bowel Disease.

about

Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data.

P2860

Q31170925-BD9C0ED7-FB02-4DC7-913F-7F0F2BE99CFA

P2860

Nutraceutical Supplements for Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q35646449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Nutraceutical Supplements for Inflammatory Bowel Disease.

@ast

Nutraceutical Supplements for Inflammatory Bowel Disease.

@en

type

Item

label

Nutraceutical Supplements for Inflammatory Bowel Disease.

@ast

Nutraceutical Supplements for Inflammatory Bowel Disease.

@en

prefLabel

Nutraceutical Supplements for Inflammatory Bowel Disease.

@ast

Nutraceutical Supplements for Inflammatory Bowel Disease.

@en

P1476

Nutraceutical Supplements for Inflammatory Bowel Disease.

@en

P2093

Berkeley N Limketkai

http://www.w3.org/2001/XMLSchema#string

Neha D Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

Vitamin D deficiency

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

Saccharomyces boulardii in maintenance treatment of Crohn's disease

A pilot trial of Saccharomyces boulardii in ulcerative colitis

Therapy of active Crohn disease with Boswellia serrata extract H 15

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

P304

551-558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0884533615586598

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerard Mullin

Alyssa Parian

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26024677

http://www.w3.org/2001/XMLSchema#string

Nutraceutical Supplements for Inflammatory Bowel Disease.

about

P2860

P2860

Nutraceutical Supplements for Inflammatory Bowel Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698